Breakfast meeting of the hottest global business l

Breakfast meeting of global business leaders | Varian Zhang Xiao: AI will greatly change China's medical and health industry

10:07 source: Economic Observer/

original title: breakfast meeting of global business leaders | Varian Zhang Xiao: AI will greatly change China's medical and health industry

(picture source: respondents provide pictures)

Economic Observer Shen Jianyuan Varian Medical System Company, founded in 1948, is the first high-tech company to settle in Silicon Valley, California. Today, as the world's leading provider of diagnosis and treatment solutions for cancer and other major diseases. Varian designs and manufactures advanced equipment and software products for cancer radiotherapy, as well as imaging components for imaging and security applications. Global sales exceeded $3.3 billion

Varian has been involved in the development and research of proton therapy technology since the 1990s. In 2009, it officially entered the market of proton therapy system and its treatment technology and radiotherapy integration informatization, and quickly established the proton therapy business with superconducting cyclotron and pen beam scanning technology as the advanced technology platform, and obtained excellent market recognition and strong market competitiveness

Varian has entered the Chinese market for more than 30 years. In 2007, it established a Chinese factory and regional headquarters in Beijing Economic and Technological Development Zone, and established the company's only linear accelerator production base outside North America

in October 2018, Varian announced that in order to support the training of Chinese radiotherapy professionals, it would carry out the "radiotherapy nova" project for Chinese universities, donate leading Varian oncology software to universities with medical physics or radiotherapy majors, and provide the required corresponding computer hardware

Varian hopes to take this opportunity to support relevant Chinese colleges and universities to vigorously develop plastic granulator technology using renewable energy and industrial waste heat, carry out teaching work in line with the world's top clinical practice, help college students learn the world's most advanced oncology software and facilities based on big data and human intelligence in a real software environment, and improve their clinical practice ability and employment competitiveness through practical learning and exercise. Varian also hopes to provide the most advanced oncology software and facilities for colleges and universities, help colleges and universities carry out scientific research work consistent with the world's advanced level, and improve the overall academic ability of colleges and universities

since the establishment of the Asia Pacific Education Center in Beijing in 2008, Varian has provided clinical professional training for oncologists, medical physicists, technicians and maintenance engineers, and has trained more than 3500 professionals for China's radiotherapy industry. Varian has installed more than 700 radiotherapy equipment in China to treat more than 500000 Chinese cancer patients every year

Dr. Zhang Xiao, the global vice president and President of Greater China of Varian Medical Systems, joined Varian Medical Systems in 2013 to take charge of the company's comprehensive business work in radiotherapy, proton therapy and X-ray imaging components. In 2014, he was promoted to global vice president and President of Greater China. His business scope covers China, Taiwan, Hong Kong and Macao special administrative regions

during the Expo, according to Dr. Zhang Xiao's introduction at the 2018 global business leaders' breakfast meeting with the theme of "integration and evolution" jointly held by the economic observer and the China International Import Expo Bureau,

Varian launched the "Varian smart cloud 4.0 radiotherapy platform Hospital Consortium" solution in China, which is the first complete smart radiotherapy cloud in the industry, which can truly integrate people, machines, big data and IOT. This plan can promote radiotherapy from the top three hospitals in big cities to the grass-roots hospitals of the radiotherapy Medical Association, and ensure that the grass-roots hospitals carry out safe, effective and high-quality radiotherapy, so as to "consolidate the top three hospitals and go to the grass-roots level". It can make the treatment of cancer more popular, especially improve the 5-year survival rate of rural patients

its intelligent accelerator vitalbeam is called "radiotherapy Superman" by customers. Through a complete intelligent platform, it can provide a complete and guaranteed graded specialist treatment plan, which is the first innovation in the medical industry

probeam, its high-end technology, is the first system in the world that can implement fully integrated intensity modulated proton therapy. Proton therapy provides patients with a treatment that can not only reduce the impact on normal tissues and organs, but also effectively kill cancer cells. Varian currently provides equipment, software and services to 23 leading proton centers around the world. Among them, Hefei ion medical center, the first government funded medical center in China, Guangzhou Taihe cancer hospital and Taiwan University Cancer Center are currently in the process of design and construction to ensure that China's cancer treatment technology is in line with the world's cutting-edge level

Zhang Xiao said: "I aim to push graphene and other two-dimensional materials from the laboratory to the society. People believe that the treatment center of artificial intelligence can also be launched in China in the near future, especially in areas where medical resources are relatively scarce in China. On the one hand, I am shocked, on the other hand, I am happy. Everything is connected, everything is digitalized and everything is intelligently integrated. I believe this is a great change factor for the future medical industry."

Varian is mainly an enterprise for cancer treatment. From a radiotherapy based company founded in Silicon Valley around 1940, it began to expand to the whole industry chain of cancer treatment, and has acquired six companies in the past year. Peek has become a company with good flame retardancy, focusing on technology and radiotherapy. Transformation to a cancer diagnosis, treatment, rehabilitation, full service chain, and patient-centered service industry platform company

Zhang Xiao believes that the rapid development of artificial intelligence in just a few years has brought changes to the field of health care, which is no less than the application of artificial intelligence in other fields. "We believe that AI treatment centers can also be launched in China in the near future, especially in areas where medical resources are relatively scarce in China. On the one hand, I am shocked, on the other hand, I am delighted. Everything is connected, everything is digitalized, and everything is intelligently integrated. I believe this is a great change factor for the future medical industry. As a practitioner of the medical industry, I am full of confidence in this." He said, "at present, we treat about 510000 patients every year, and we hope to double to 1million within five years."

the following is based on the interview of Zhang Xiao, global vice president and President of Greater China of Varian Medical Systems, at the 2018 global business leaders' breakfast meeting with the theme of "integration and evolution" jointly held by the economic observer and the China International Import Expo Bureau in Shanghai on November 6 -

Economic Observer: how will Varian view the Chinese market in the next three years, What investments will be made in the new growth opportunities in the Chinese market

Zhang Xiao: at present, Varian China has become the second largest single country market of Varian in the world, and the first is the United States. With the continuous improvement of the life of the Chinese people, the aging of the population is constantly strengthening, and the life span of people is also constantly extending. The biggest gene of cancer is not the environment, but the population, especially age. From this perspective, the number of cancers in our country will increase

Varian's radiotherapy, as one of the three main treatment methods in the field of cancer treatment (surgery, radiotherapy, chemotherapy), has been in line with the radical cure rate of surgery for cancer. From a technical point of view, our business focus will be how to help this country solve the treatment problem of cancer patients

the task given to us by Wali safety ball is no longer based on sales volume, but whether we can double the number of patients treated in China every year. At present, we treat about 510000 patients every year, and we hope to double to 1million within five years

Varian will continue to invest in China to help cultivate radiotherapy talents in the Chinese market through research and development, personnel, various training institutions, and cooperation between institutions and colleges

compared with developed countries, the main reason for the relative backwardness of radiotherapy in China is largely due to the lack of medical physics talents. There are only more than 3000 in China, while there are more than 15000 in the United States, which is a big gap. At the same time, Varian also continues to practice his own society and meet the goal of 50% of cancer treated with radiotherapy proposed by the World Health Organization

Economic Observer: how can we achieve the KPI assessment of the number of treatment

Zhang Xiao: this problem is very good. According to the speed of cancer development in China, if we gradually train talents from schools, it is far from enough to confirm the actuator's clearance, friction, leakage and many other parameters mainly according to the overall performance requirements of the system in the design. Especially in China, the whole medical resources are mostly concentrated in big cities. In my opinion, to help China develop a professional medical consortium with radiation as its specialty, we must use a lot of artificial intelligence, big data and industrial IOT technology to achieve this goal, so that our human factors and talent needs are largely replaced by modern technology. At the same time, through the industrial IOT technology, we can remotely ensure quality control, process management, and achieve the treatment level required by our country

Economic Observer: as a multinational enterprise, how can it not only comply with the rules related to policies, but also meet the services of the whole patient population

Zhang Xiao: Varian has been on the road of artificial intelligence and big data for many years. This is not a plan, but also a realization. Beijing Cancer Hospital has used our big data medical planning software. We are still developing in this area. The current product is not entirely a hardware, but a complete ecological environment of hardware + big data + artificial intelligence + industrial IOT. This is a specially tailored solution for the promotion of grass-roots radiotherapy in China

what are Varian's important achievements at the first China International Fair of the economic observer

Zhang Xiao: we signed a series of contracts with our partners in all provinces at the China International Fair, including the new technology of proton system. We believe that if these technologies are put into practice in China, they may change the face of the whole radiotherapy industry. Make efficiency, quality and price reach a new level. In the past, a proton therapy may need 270000, but now the price may be cheaper than the current ordinary cancer radiotherapy. We are very confident that we can work with these medical partners in China and hope that in the near future, cancer can be truly controlled as a common disease

:

statement: This article only represents the author himself. Sohu is an information publishing platform, and Sohu only provides information storage space services

reading ()